rfhg_52342.1

Basic information about the TSS

---

TSS ID: rfhg_52342.1 Species: human Chr: chr3		Start: 160565372 End: 160565424 Strand: -
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3508588,EH38E2253527)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000678630.1:0 GeneID: 3840 HGNC/MGI_ID: HGNC:6397 UniProt_ID: Nearer transcript ids and distances:

Gene_name: KPNA4 Gene_symbol: KPNA4 Gene_synonyms: IPOA3 MGC12217 MGC26703 QIP1 SRP3 Gene_source: HGNC:6397

TATA-Box annotation

---

Distance to TSS:	173
Nearest PromoterID:	NM_002268
Entrez ID:	3840
Nearest Unigene:	Hs.467866
Nearest Refseq:	NM_002268
Nearest Ensembl:	ENSG00000186432
Gene Name:	KPNA4
Gene Alias:	IPOA3|QIP1|SRP3
Gene Type:	protein-coding
CpG%:	0.115385
GC%:	0.735849
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@KPNA4 p2@KPNA4 p3@KPNA4 p5@KPNA4 p7@KPNA4 p8@KPNA4 p10@KPNA4
Sample		p1@KPNA4	p2@KPNA4	p3@KPNA4	p5@KPNA4	p7@KPNA4	p8@KPNA4	p10@KPNA4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	13.25	24.16	1.56	0.97	0.97	1.56	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	10.52	16.79	1.42	1.01	0.61	2.23	2.43
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	17.75	26.23	1.93	0.58	0.19	2.12	3.28
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	13.72	23.49	2.70	0.62	0.42	5.61	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	14.85	21.60	2.70	0.67	1.57	4.50	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	11.24	24.23	2.91	0.58	0.97	4.07	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	21.79	29.20	2.40	0.22	1.31	6.75	4.58
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	13.56	18.89	1.45	0.48	0.73	4.84	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	16.24	23.30	1.92	0.00	0.21	4.70	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	26.66	29.56	2.90	1.74	1.74	2.32	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.17	22.23	1.62	0.81	0.40	1.62	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	16.67	28.05	1.22	0.81	0.00	2.85	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	13.22	12.57	0.97	0.16	0.32	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.33	15.34	1.20	0.45	0.45	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	10.98	11.20	0.66	0.00	0.44	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.56	15.59	1.01	0.25	0.75	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.27	13.54	0.44	0.22	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.39	12.65	1.69	0.00	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	12.26	18.66	3.73	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.33	12.49	1.50	0.15	0.15	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.03	13.90	1.47	0.67	0.27	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.88	11.74	2.24	0.17	0.52	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.44	15.25	0.90	0.13	0.39	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.95	17.71	1.70	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	14.45	12.64	1.29	0.52	0.26	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.98	13.93	0.32	0.32	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.19	16.48	1.65	0.00	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	14.62	18.86	2.36	0.24	1.18	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.01	14.70	0.97	0.48	0.81	0.32	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.57	16.47	1.63	0.00	0.72	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.72	13.61	0.84	0.00	1.26	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.79	15.04	1.37	0.00	0.00	0.78	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	12.03	14.35	0.63	0.63	0.63	0.21	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	14.84	20.45	1.65	0.33	0.82	0.00	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	15.15	15.89	0.37	0.75	0.56	0.37	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.37	16.67	1.92	0.19	0.00	0.00	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	14.92	17.99	2.25	0.00	0.61	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.90	12.90	0.20	0.20	0.40	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.42	15.13	2.16	0.27	0.00	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.08	15.12	0.24	0.24	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	15.29	17.17	0.24	0.24	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.37	19.18	2.64	0.73	0.73	0.00	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	16.24	17.50	1.69	1.05	0.00	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.24	16.26	1.92	0.17	0.87	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	15.26	13.25	1.41	0.80	0.00	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	13.49	15.59	1.63	0.70	0.47	0.23	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	14.39	15.35	0.96	0.24	0.48	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.60	12.22	2.98	0.89	0.30	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	16.04	15.56	0.24	0.96	0.96	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	12.74	18.00	1.42	0.61	0.40	0.40	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	16.40	15.99	1.84	0.82	0.41	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.68	18.23	0.89	0.44	0.00	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	125.93	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.58	14.90	0.71	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	8.95	13.92	0.33	0.00	0.66	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	31.88	38.59	5.03	0.00	1.68	0.00	6.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	18.83	23.42	2.30	0.92	0.46	0.46	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.94	20.42	0.65	1.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.02	8.03	0.64	0.00	0.64	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	15.72	17.60	0.94	0.31	2.20	0.00	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.87	11.28	1.41	0.71	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.85	14.58	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.90	26.27	2.39	1.59	2.39	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	13.59	15.97	1.02	0.34	0.34	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.65	12.02	0.32	0.32	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.84	12.78	0.35	0.71	0.35	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	80.82	32.33	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	71.08	118.46	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	12.19	13.65	0.49	0.49	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	18.35	20.83	0.50	0.00	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	18.30	19.23	0.00	0.00	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	17.55	16.56	0.99	0.33	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.99	12.68	0.62	0.00	0.00	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.98	9.17	0.00	0.00	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	26.93	19.96	2.22	0.32	0.00	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	20.53	21.18	1.76	0.48	0.64	0.00	0.48
Adipocyte - omental, donor1	11473-119C6	29.39	23.41	2.67	0.64	0.25	0.13	0.25
Adipocyte - omental, donor2	11474-119C7	15.70	18.69	0.00	0.00	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	7.37	10.72	1.34	0.67	0.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	8.93	12.12	1.28	0.00	0.00	0.64	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	4.40	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	16.71	16.71	1.35	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	10.25	6.78	0.00	0.00	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	17.60	9.19	0.39	0.20	0.20	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	9.01	10.30	0.26	0.26	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	25.93	14.22	1.95	0.00	0.00	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	22.92	19.99	0.59	0.00	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	23.41	19.30	1.53	0.24	0.48	0.00	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	19.69	12.91	1.94	0.00	0.00	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	26.13	25.59	1.07	1.07	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	19.48	16.69	2.78	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	21.63	14.56	0.83	0.00	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.55	9.80	1.51	0.25	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	20.94	21.27	0.65	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	24.66	15.53	1.22	0.00	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	4.64	5.97	2.21	0.44	0.22	0.22	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	5.02	0.36	0.00	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	3.59	0.00	0.00	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	5.22	10.25	1.26	0.18	0.54	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	8.37	0.00	0.00	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.63	9.25	0.21	0.21	1.44	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	19.91	17.05	2.52	0.11	0.11	0.00	0.57
Anulus Pulposus Cell, donor2	11463-119B5	11.51	12.49	2.45	0.24	0.24	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	7.64	9.88	3.59	0.00	1.35	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	14.33	1.30	0.00	0.00	1.30	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	17.12	2.14	0.00	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	13.75	19.13	1.49	0.30	1.49	0.90	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	15.18	6.32	0.00	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.20	9.90	1.32	0.00	0.66	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.72	11.70	3.90	0.32	0.65	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	13.11	17.48	2.43	0.97	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.03	12.47	2.38	0.00	0.00	1.19	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	8.29	9.42	1.13	0.00	1.51	0.38	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	14.51	15.24	2.18	0.00	0.73	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	10.03	1.25	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	20.26	18.94	2.14	0.66	0.33	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	21.84	2.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	11.31	12.21	1.66	0.45	0.15	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	11.79	15.00	2.14	0.00	1.07	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.82	22.67	3.59	0.57	0.57	0.94	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	15.77	16.04	2.41	0.27	0.00	0.27	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	17.56	17.56	2.93	0.00	0.98	0.98	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.11	15.92	3.15	0.17	0.83	1.00	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	25.22	2.40	1.20	1.20	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	17.70	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.38	12.69	2.06	0.51	0.69	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	16.78	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.71	22.81	3.40	0.00	0.49	0.49	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	13.66	17.83	1.90	0.00	0.38	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	14.54	2.42	0.00	1.21	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.25	15.39	1.14	0.00	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	13.47	17.32	1.50	0.86	0.00	0.64	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.36	16.78	0.52	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.98	16.42	0.94	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	15.11	15.11	1.93	0.00	0.96	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	10.70	16.41	0.71	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.70	15.21	2.34	0.00	1.17	2.34	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.55	15.35	2.11	0.00	0.30	0.60	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	11.88	1.19	0.00	0.00	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	12.71	12.71	3.05	0.00	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	13.24	15.54	1.27	0.25	2.04	0.76	2.04
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	11.44	13.98	0.00	0.00	0.00	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.65	15.10	0.86	0.43	0.43	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.12	15.24	1.91	0.42	0.00	1.06	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	9.57	9.86	0.87	0.00	0.00	0.58	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	15.12	0.94	0.00	0.00	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	9.66	12.71	1.19	0.34	0.68	1.19	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	25.48	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	12.68	0.00	0.00	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.72	11.79	0.86	0.64	0.21	1.07	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.03	21.06	3.61	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	13.85	2.19	0.73	0.00	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.33	16.78	2.30	0.23	0.46	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	17.85	2.55	0.00	0.00	0.00	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.69	13.22	2.54	0.00	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.31	18.37	3.51	0.41	0.41	0.41	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.91	16.52	1.22	0.92	0.31	0.61	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	18.16	22.47	1.43	0.00	0.48	0.96	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	12.42	15.74	2.44	0.44	0.22	0.89	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	19.84	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.08	16.62	1.66	0.55	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	14.56	20.12	2.65	0.26	0.00	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	15.99	13.45	1.82	0.36	1.09	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	7.86	6.39	0.74	0.00	0.12	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	7.02	5.65	0.17	0.17	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.45	3.99	0.63	0.00	0.21	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	27.54	18.13	1.39	0.00	0.35	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	24.43	22.81	1.94	0.81	1.29	0.16	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	24.16	19.69	1.49	0.15	1.19	0.00	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	20.07	10.21	0.69	0.57	0.69	0.11	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	26.69	13.53	0.38	0.75	0.75	0.00	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	22.99	15.48	1.14	0.46	1.37	0.00	0.11
Basophils, donor1	12241-129G9	36.61	23.80	4.97	2.09	0.26	0.00	0.00
Basophils, donor2	12242-129H1	54.48	55.92	14.43	6.86	2.53	0.36	1.08
Basophils, donor3	12243-129H2	24.55	25.58	3.09	1.18	1.18	0.88	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	6.04	2.80	0.22	0.00	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.11	1.37	0.46	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	21.52	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.20	21.97	0.63	0.00	0.63	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	17.47	14.76	2.08	0.83	0.21	0.62	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	20.27	27.17	1.15	0.00	0.00	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	13.32	10.80	0.72	0.00	0.72	0.54	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	20.10	24.01	1.24	2.27	0.31	0.00	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	39.13	37.96	2.10	2.10	0.70	0.00	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.54	18.23	2.56	0.96	0.96	2.24	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	31.03	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	29.87	21.42	1.69	2.25	1.13	1.69	0.56
CD14+ Monocytes, donor2	11305-117B9	20.97	22.46	2.97	1.48	1.48	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	21.51	18.66	2.41	0.66	1.10	0.88	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	30.29	17.27	0.85	1.42	0.28	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	37.91	21.99	2.27	1.14	0.76	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.56	21.37	2.63	0.66	0.33	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	45.68	44.52	3.90	2.46	0.58	1.01	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	39.53	47.07	6.94	3.32	0.60	1.51	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	45.25	40.75	5.45	1.90	0.47	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	48.04	54.91	3.68	2.01	0.17	0.67	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	49.68	79.49	8.56	2.21	0.55	1.10	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	53.80	78.10	5.21	4.46	0.25	3.97	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	61.48	74.01	4.50	2.55	0.39	1.76	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	51.99	58.40	4.45	2.31	0.36	1.78	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	62.02	68.55	8.71	4.35	2.39	3.70	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	58.06	109.57	8.90	1.17	1.40	4.92	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	73.92	99.80	6.86	3.70	0.00	3.70	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	65.45	89.86	11.09	3.33	0.00	7.77	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	43.43	46.11	3.42	1.19	0.89	0.45	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	35.92	54.68	4.79	5.19	0.40	1.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	48.09	56.21	8.54	3.12	1.25	0.62	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	55.59	97.69	5.49	2.29	1.14	4.80	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	62.66	82.11	8.82	4.30	1.58	5.66	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	58.92	94.28	8.73	1.75	2.18	6.55	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	62.41	53.53	4.03	0.81	0.00	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	52.69	42.92	4.19	2.79	0.52	1.05	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	58.07	53.87	3.79	1.26	0.42	0.42	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	60.26	79.36	4.59	2.94	1.47	4.04	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	69.04	107.44	7.75	3.17	0.00	1.76	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	56.60	77.65	6.14	3.51	1.32	3.95	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	65.91	88.23	7.50	4.01	0.52	3.31	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	53.52	86.60	5.58	2.97	1.12	4.83	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	70.27	81.48	8.19	4.10	1.51	6.25	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	57.74	61.42	5.32	0.82	0.00	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	56.33	86.00	8.81	1.85	0.23	3.25	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	60.09	66.58	6.50	2.55	2.09	3.02	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	16.13	11.33	1.74	0.44	0.22	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	25.41	14.09	1.39	0.46	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	14.51	9.53	0.87	0.00	0.22	0.22	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	27.56	15.88	0.93	0.62	0.62	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	31.61	14.50	2.10	0.17	0.00	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	36.12	21.63	2.45	0.22	0.89	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	23.48	16.33	3.57	0.51	0.26	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	20.86	16.25	4.83	0.44	0.88	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	19.37	17.26	2.53	0.21	0.42	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	36.58	14.23	4.06	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	32.54	22.37	2.03	2.71	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	38.32	21.75	3.11	1.04	3.11	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	41.04	24.52	7.46	4.80	0.53	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	45.57	23.05	2.68	2.14	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	32.29	18.95	0.70	2.11	1.40	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	37.65	24.31	3.92	2.35	1.57	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	54.05	17.14	2.64	0.00	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	23.84	24.66	5.75	4.11	1.64	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	19.59	14.51	2.90	2.90	1.45	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	21.71	20.19	2.52	5.55	2.52	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	48.89	28.28	0.81	0.40	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	27.96	16.78	0.40	0.00	0.80	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	22.09	19.08	4.02	2.01	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	15.73	20.23	4.49	5.06	3.37	2.81	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	27.05	15.03	1.13	1.50	0.75	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	27.96	18.04	2.48	1.35	0.68	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	18.92	29.28	4.28	6.43	6.43	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	23.88	22.05	6.74	3.67	7.96	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	25.31	33.24	7.62	5.49	3.96	0.00	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	23.23	12.00	1.53	2.04	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	25.38	15.05	1.80	1.57	0.90	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	27.88	14.37	4.02	3.16	0.29	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	22.76	22.28	7.59	4.27	3.79	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	20.37	16.86	2.11	3.51	3.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	13.18	6.59	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	17.78	11.99	2.89	3.32	0.87	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	21.01	11.52	1.36	2.20	0.68	0.00	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.34	9.83	1.93	1.77	0.32	0.00	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	14.79	13.90	5.38	1.79	2.24	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.60	13.98	2.10	2.45	1.05	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	25.52	22.88	3.08	6.60	1.76	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	23.19	15.18	4.22	3.79	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	24.10	12.47	2.91	2.49	0.83	0.00	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	16.04	9.36	1.67	0.67	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	25.83	21.75	8.43	5.44	3.81	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	24.12	20.90	8.58	4.82	1.07	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	23.31	19.73	7.17	3.59	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	27.07	18.54	2.78	2.41	0.37	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	18.20	9.96	1.30	3.47	0.65	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	22.70	11.98	3.36	2.31	0.84	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	16.68	13.15	4.04	5.56	2.53	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	27.73	16.03	2.17	9.10	2.17	0.00	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	27.02	21.79	4.79	7.41	1.74	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	40.08	21.28	4.95	6.93	2.47	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	29.54	14.77	4.62	4.62	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	30.71	22.33	4.19	8.37	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	52.62	30.19	4.43	6.09	1.38	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	49.08	33.86	4.66	5.15	1.72	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	58.52	20.02	1.54	4.62	0.00	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	53.36	25.78	5.01	8.59	1.43	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	51.24	34.62	6.92	9.69	6.92	1.38	1.38
CD8+ T Cells, donor1	11226-116C2	25.54	42.23	7.86	9.82	2.29	0.33	0.65
CD8+ T Cells, donor2	11307-117C2	13.89	25.90	5.26	5.26	4.88	0.00	1.50
CD8+ T Cells, donor3	11383-118B6	17.17	28.53	7.57	6.31	4.54	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.08	7.57	1.38	0.92	0.92	0.23	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	9.83	11.50	1.20	0.24	0.96	0.48	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.50	11.22	2.19	0.27	0.55	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	13.81	13.81	1.50	0.90	0.30	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	17.04	21.12	1.92	0.72	0.96	1.44	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	12.05	15.23	1.82	0.68	0.45	0.68	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	9.13	13.04	1.74	0.00	0.65	0.00	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	9.48	13.69	1.32	0.53	0.53	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	13.37	16.42	2.11	0.70	0.23	0.00	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	14.19	12.38	1.51	0.30	0.60	0.30	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.33	9.59	0.87	0.29	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.92	14.12	1.60	0.27	0.00	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	12.69	21.01	2.63	1.75	0.88	1.75	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.47	21.41	1.82	0.46	0.91	1.82	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	13.43	20.14	0.00	0.75	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	9.00	13.33	2.16	0.00	0.72	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	11.51	15.54	0.86	0.86	0.00	0.00	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	14.38	13.67	0.94	0.94	0.00	0.94	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10.46	14.58	2.54	0.32	0.32	0.00	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	13.53	16.61	2.46	0.62	0.00	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.58	15.71	1.28	0.96	0.32	0.00	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	12.24	17.59	1.53	1.15	0.76	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.79	13.01	1.97	0.39	0.39	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.86	15.13	0.76	0.00	0.76	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	18.47	29.71	3.21	1.61	0.80	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	17.49	30.08	2.10	2.10	0.70	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	23.04	46.08	6.01	0.00	0.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	38.38	20.11	12.79	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	5.43	17.79	0.99	0.00	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	13.26	10.73	1.26	0.21	0.63	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	14.56	15.60	0.35	0.35	0.69	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	14.57	23.45	2.13	0.00	0.36	0.00	0.71
Chondrocyte - de diff, donor3	11410-118E6	7.74	7.05	0.80	0.34	1.14	0.00	0.80
Chondrocyte - re diff, donor2	11339-117F7	17.91	26.86	4.48	0.90	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	11.32	11.32	1.21	0.81	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	29.95	22.26	1.72	0.46	0.69	0.80	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	22.23	25.01	2.35	0.21	0.43	0.43	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	22.48	25.40	2.21	0.35	0.88	0.44	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	40.72	25.22	5.04	0.92	0.64	0.00	0.00
Corneal Epithelial Cells, donor1	11526-119I5	2.42	3.51	0.44	0.22	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	6.83	3.41	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.65	4.09	0.51	0.00	0.77	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	62.08	38.80	2.97	1.16	0.17	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	55.20	42.58	3.15	1.89	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	20.70	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.87	18.25	2.05	1.08	0.76	0.11	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	15.37	16.40	3.76	3.07	3.76	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	19.59	22.20	3.26	7.83	1.96	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	18.39	30.49	3.39	9.19	5.32	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	32.69	36.86	3.67	0.50	0.17	1.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	14.08	22.88	0.59	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	16.40	23.47	1.70	0.28	0.00	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	32.63	34.60	3.54	1.57	0.00	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	7.85	6.69	0.00	0.29	0.29	1.16	0.29
Endothelial Cells - Artery, donor2	11341-117F9	22.82	43.76	1.41	1.18	0.47	1.18	0.47
Endothelial Cells - Artery, donor3	11413-118E9	27.52	34.54	4.73	1.05	0.35	1.05	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	18.62	31.70	0.89	1.99	0.44	1.33	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	21.91	29.51	1.83	0.91	0.30	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.66	19.73	0.85	0.85	0.85	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	9.21	13.37	0.30	0.89	0.30	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	22.39	32.28	4.17	0.00	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	3.40	7.66	0.43	0.14	0.43	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	13.60	20.01	0.40	0.40	1.60	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	11.01	17.82	2.62	0.00	0.52	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	31.31	30.69	1.74	0.62	0.75	0.87	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	33.46	36.07	2.82	0.87	0.87	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	49.10	42.62	3.18	0.49	0.49	0.73	0.12
Endothelial Cells - Vein, donor1	11267-116G7	14.79	28.44	3.41	0.00	0.00	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	35.62	37.02	4.89	0.00	0.70	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	23.39	40.66	3.45	0.47	0.94	1.26	0.16
Eosinophils, donor1	12244-129H3	76.23	91.48	15.25	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	283.85	232.69	28.05	11.55	6.60	0.00	0.00
Eosinophils, donor3	12246-129H5	278.21	221.14	24.97	7.13	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.91	2.44	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	15.60	30.79	2.46	0.41	0.82	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.88	8.54	0.77	0.11	0.44	0.22	0.66
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.11	12.78	0.98	0.33	0.33	0.33	1.73
Fibroblast - Aortic Adventitial, donor1	11245-116E3	16.62	16.01	2.91	0.36	0.85	0.24	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	32.48	37.53	4.37	0.14	0.82	0.55	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.71	18.04	1.69	0.21	0.11	0.11	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.54	13.70	1.05	0.26	0.00	1.58	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	16.28	21.93	1.66	0.33	2.33	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	15.42	31.75	1.36	0.00	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	18.95	24.25	2.27	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	6.31	10.88	1.58	0.16	0.32	0.63	0.16
Fibroblast - Cardiac, donor4	11452-119A3	20.61	21.22	1.82	0.30	0.61	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	18.15	21.83	1.40	0.38	0.89	0.51	0.13
Fibroblast - Cardiac, donor6	11460-119B2	19.10	20.92	2.12	0.15	0.45	0.30	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	9.51	7.77	0.40	0.13	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	18.98	19.85	2.59	0.86	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	29.30	20.51	1.46	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	11.30	14.76	0.92	0.00	0.46	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	23.91	16.96	1.87	0.17	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	11.50	9.39	1.41	1.17	0.47	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	29.72	31.13	5.19	0.47	0.00	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	11.61	9.43	0.48	0.12	0.97	0.36	0.12
Fibroblast - Dermal, donor4	11450-119A1	18.77	17.30	0.68	0.23	0.34	0.34	0.57
Fibroblast - Dermal, donor5	11454-119A5	20.93	23.90	1.22	0.17	0.00	0.17	0.17
Fibroblast - Dermal, donor6	11458-119A9	25.50	27.94	0.65	0.65	0.65	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	19.78	14.78	1.25	0.00	0.83	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	36.68	29.87	4.45	0.79	0.52	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	22.14	17.53	2.24	0.26	0.26	0.00	0.66
Fibroblast - Gingival, donor3	11394-118C8	21.08	17.98	1.06	0.29	0.39	0.00	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	27.01	24.93	4.16	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.26	22.20	0.70	0.18	0.35	0.00	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	43.03	38.51	2.18	0.62	0.62	0.62	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	38.00	28.94	2.16	0.14	0.41	0.00	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	45.17	27.17	3.88	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	45.77	32.47	3.66	0.29	0.15	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	41.59	32.72	3.68	0.55	0.14	0.14	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	58.36	53.31	4.39	0.88	0.77	0.77	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	33.60	22.60	5.28	0.44	0.73	0.15	0.15
Fibroblast - Lung, donor1	11270-116H1	6.80	13.59	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	11.94	11.94	0.00	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	14.98	18.99	0.63	0.00	0.42	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	8.33	0.00	0.00	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	1.40	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.36	2.24	0.56	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	9.34	8.53	0.41	0.41	0.41	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	19.97	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	17.87	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	30.65	23.08	0.78	0.58	0.19	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	26.85	21.39	2.58	0.91	0.76	0.15	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	28.76	26.31	1.53	0.31	0.61	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.71	29.39	1.53	0.76	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	21.06	24.84	2.43	0.27	0.00	0.27	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	24.59	22.96	1.51	0.58	0.58	0.00	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	19.90	21.22	2.54	0.44	0.55	0.44	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.31	7.31	1.22	0.20	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	12.70	13.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	10.28	8.70	0.79	0.00	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	21.43	32.15	2.58	0.60	0.20	1.79	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.06	10.66	1.95	0.18	0.00	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.01	14.98	2.96	0.39	0.59	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.35	25.87	1.20	0.00	0.00	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	17.38	17.27	2.05	0.32	0.43	0.43	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	17.97	21.26	4.30	1.01	0.51	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	14.93	18.05	3.12	0.33	0.00	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	37.49	33.28	3.21	1.00	1.60	1.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	16.17	14.17	2.41	0.20	0.70	0.30	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	19.34	29.01	1.81	0.30	0.60	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	13.84	13.67	1.82	0.25	0.50	0.25	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	15.56	12.99	1.71	0.34	0.17	0.00	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	18.39	26.27	1.31	0.00	0.66	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	16.08	18.96	1.38	0.11	0.75	0.32	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	13.83	15.52	2.02	0.51	0.84	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.31	16.31	2.20	0.00	1.41	0.00	2.20
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	88.64	0.00	0.00	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	33.99	16.56	4.36	0.87	1.74	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	46.46	32.59	4.68	1.21	1.04	0.69	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	39.30	29.67	2.60	0.78	0.78	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	41.90	35.52	4.09	1.79	1.79	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	41.34	38.28	2.30	1.53	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	45.94	40.84	5.10	0.00	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	34.80	31.95	1.71	1.43	2.57	0.29	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	34.19	18.48	1.65	0.83	1.93	0.00	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	39.73	26.03	1.14	0.46	1.14	0.23	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	36.46	39.03	1.59	0.59	1.39	0.20	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	36.48	14.27	1.32	1.06	0.79	0.00	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	29.68	30.33	2.94	1.96	0.65	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	25.65	29.19	2.65	0.44	1.33	1.77	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	29.68	26.43	1.84	0.28	0.42	0.14	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	35.22	28.94	2.71	0.99	0.62	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	23.64	23.37	1.88	1.07	1.07	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	49.06	71.73	3.35	0.99	0.25	0.62	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	51.22	52.60	3.32	0.97	0.97	0.83	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	43.71	41.68	3.66	0.61	1.42	1.22	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	23.96	37.65	1.14	0.68	0.23	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.24	47.71	3.11	1.00	1.00	0.50	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	51.15	61.64	3.93	0.87	1.09	1.09	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.34	23.05	2.07	0.30	0.59	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	27.82	38.47	3.18	0.79	0.48	0.00	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	24.35	32.62	1.12	0.22	1.12	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	17.54	21.78	1.01	0.00	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	26.29	30.87	3.73	0.51	0.85	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	53.03	57.19	4.79	0.98	0.44	0.80	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.78	24.45	1.46	0.94	0.83	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.83	20.49	1.02	0.34	0.34	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	24.90	26.34	3.98	0.44	0.55	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.34	40.18	3.08	0.50	0.17	0.17	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	39.61	38.59	3.06	0.82	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	20.84	27.03	1.03	0.00	1.24	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	21.21	26.29	2.19	0.23	1.15	0.00	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	22.35	21.68	2.17	0.33	1.50	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	19.18	15.43	1.76	0.22	0.88	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	24.72	26.07	2.58	0.37	1.11	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	27.23	29.66	0.65	0.49	0.81	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.02	26.30	1.60	0.00	0.32	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	21.60	21.79	2.75	0.28	0.95	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	18.19	19.46	1.11	0.63	0.47	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	30.41	24.33	1.52	0.61	0.00	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.55	18.09	2.09	0.63	0.63	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	20.42	19.10	2.42	1.10	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	20.76	22.16	0.84	0.84	0.00	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	25.46	28.24	3.15	0.56	0.74	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	17.92	17.11	2.14	0.53	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	22.80	26.78	1.84	0.61	0.46	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.08	25.78	3.24	0.39	0.52	0.13	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	23.85	19.79	1.90	0.00	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	19.36	18.80	3.50	0.37	0.18	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	17.55	19.08	1.97	0.44	0.66	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	39.67	32.73	4.96	0.00	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	25.06	30.47	1.98	0.66	0.26	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.81	24.61	1.82	0.00	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	34.57	29.74	2.54	0.51	0.76	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	44.99	41.80	1.79	0.60	1.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	36.98	28.50	2.16	0.62	0.46	0.15	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	55.65	48.69	2.05	0.82	1.02	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	24.10	17.84	2.19	0.00	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	18.37	21.19	1.70	0.28	0.28	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	31.82	26.75	3.23	0.92	1.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	51.97	22.27	4.95	0.00	0.00	0.00	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	22.82	18.18	2.32	0.77	1.16	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	24.07	14.44	1.60	1.60	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	24.34	3.48	0.00	3.48	0.00	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.09	23.11	1.30	0.65	1.95	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	17.30	16.06	1.65	0.82	0.00	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	26.66	0.00	0.00	6.66	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	21.53	15.10	1.12	0.56	0.84	0.00	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	16.67	24.84	1.31	1.31	2.61	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	14.26	13.42	0.84	0.84	0.84	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	24.81	16.22	0.64	0.95	0.00	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	15.28	11.55	0.00	0.34	1.02	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	16.71	16.71	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	30.93	21.76	1.72	0.00	0.00	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.66	11.25	0.59	0.00	0.89	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	11.86	1.69	0.00	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	14.91	22.37	0.41	0.41	0.83	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	15.42	17.95	0.69	0.92	1.61	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	27.68	16.91	1.92	0.77	0.77	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	10.11	7.82	1.63	0.33	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	7.36	7.36	0.67	1.34	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	13.87	17.34	0.00	0.77	0.77	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	13.69	22.25	2.05	0.68	1.37	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	24.85	0.00	2.48	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	12.27	11.32	0.94	1.42	0.94	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	6.64	8.45	1.21	0.00	1.21	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	14.24	15.26	0.51	1.02	0.51	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	32.31	24.33	1.60	1.20	1.20	0.00	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	16.28	13.32	0.49	0.49	0.49	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	18.89	25.97	1.18	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.84	23.34	2.92	1.75	1.17	0.00	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	18.43	9.66	0.44	0.44	1.32	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.11	14.41	0.85	0.00	2.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	17.31	19.10	0.60	1.19	1.19	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	11.65	16.50	0.97	0.49	2.43	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	17.12	2.28	1.14	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.81	9.56	0.42	0.42	0.00	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	16.87	3.37	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	15.54	12.69	1.59	0.00	0.63	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.10	7.94	1.25	0.00	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	16.36	14.16	1.97	0.46	0.58	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	16.37	16.20	2.53	0.34	0.34	0.17	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.38	13.88	1.14	0.00	0.00	0.00	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	16.18	14.32	1.97	0.66	0.44	0.00	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	15.69	16.12	1.72	0.00	0.64	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	12.27	13.35	1.29	0.00	0.22	0.43	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.96	11.83	1.00	0.37	0.25	0.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	17.84	14.92	2.23	0.69	0.17	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.49	12.17	1.60	0.00	0.00	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.72	7.28	0.00	1.12	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.06	5.19	1.73	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	18.51	0.00	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.05	6.70	1.06	0.00	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	3.63	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	15.74	17.83	1.92	0.35	0.35	0.00	1.05
Hepatocyte, donor1	11523-119I2	21.79	21.79	2.42	0.00	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	20.47	30.17	3.23	0.00	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	19.02	15.34	1.84	0.00	0.61	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	8.48	10.44	3.26	2.61	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	18.00	18.35	1.05	0.70	1.92	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.99	23.19	2.06	0.27	0.55	0.27	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	6.37	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	26.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	54.17	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	8.31	9.69	0.00	0.00	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	7.69	0.00	0.00	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	17.87	1.62	3.25	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	15.01	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	21.78	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	9.26	1.32	0.00	0.00	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	17.74	5.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	31.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	12.60	8.19	1.89	0.00	0.63	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	4.64	0.00	0.00	0.00	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	16.80	9.69	0.65	0.00	1.29	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	4.83	0.00	0.00	0.00	8.05	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	35.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	16.30	13.85	0.00	0.81	0.81	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	24.77	15.95	0.42	0.00	0.42	2.94	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.07	11.25	0.00	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	5.54	0.92	0.00	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	15.11	0.47	0.47	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	7.26	5.44	1.81	0.00	0.91	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	14.74	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	9.69	8.61	0.00	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	7.62	0.00	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	16.43	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	11.48	6.38	0.64	0.00	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	7.29	3.65	0.00	5.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.00	9.28	0.00	0.71	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	3.32	0.00	0.00	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.66	8.64	0.93	0.00	0.93	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	14.05	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	3.14	0.00	3.14	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	10.43	10.43	1.39	1.39	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	8.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	9.73	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	18.31	5.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	6.75	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	8.53	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	12.47	0.00	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	22.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	15.65	3.68	0.92	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	6.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5.29	8.46	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	21.05	26.03	1.22	0.24	0.24	0.08	0.08
Keratinocyte - epidermal, donor2	11349-117G8	18.15	20.50	3.51	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	13.44	10.70	0.28	0.19	1.23	0.09	0.28
Keratinocyte - oral, donor1	11251-116E9	29.97	23.61	2.84	0.45	0.68	0.34	0.79
Keratocytes, donor1	11527-119I6	8.60	13.07	0.69	0.00	0.69	0.00	0.00
Keratocytes, donor2	11607-120I5	5.86	2.34	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	23.51	19.76	2.17	0.00	0.20	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	52.75	94.51	4.40	8.79	4.40	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	9.71	30.20	5.39	1.08	1.08	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	21.45	17.53	2.88	0.12	0.58	0.00	0.58
Lens Epithelial Cells, donor3	11690-122I7	20.28	19.58	2.62	0.40	0.30	0.40	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.64	9.84	1.78	0.47	0.36	0.71	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	3.07	0.28	0.28	0.00	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.07	8.82	1.42	0.31	0.47	0.31	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4.84	8.60	0.54	0.00	0.54	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.99	4.73	0.95	0.32	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.77	3.34	0.43	0.11	0.65	0.22	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.16	7.80	4.92	0.00	0.82	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.30	3.54	0.25	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.22	5.07	0.42	0.42	0.14	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.89	12.66	2.37	0.79	0.79	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.95	8.92	0.39	0.00	0.19	0.97	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.04	2.04	0.00	0.19	0.19	0.93	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.36	9.76	0.00	0.35	0.00	0.35	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.54	6.68	0.24	0.00	0.24	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.26	2.75	0.41	0.14	0.55	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.01	8.31	1.54	0.31	0.92	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.99	6.23	0.31	0.31	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	4.39	5.31	0.73	0.55	0.37	0.55	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	4.61	6.58	1.32	0.99	0.00	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.81	3.51	0.29	0.00	0.00	0.88	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.23	2.24	0.50	0.50	0.25	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.73	9.70	0.97	0.00	0.48	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.54	9.16	0.27	0.27	0.54	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.15	6.81	0.91	0.30	0.00	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.15	5.70	0.52	0.52	0.00	0.00	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.52	14.87	0.63	0.21	1.05	1.68	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.41	7.37	0.75	0.60	0.60	0.15	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.88	6.88	2.75	0.00	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.77	9.03	1.32	0.75	0.75	0.75	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.24	4.24	0.42	0.21	0.42	0.21	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	7.75	10.66	0.48	0.48	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.96	8.60	0.99	1.65	0.00	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	3.47	2.97	0.62	0.25	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.55	13.70	1.11	1.48	0.74	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.15	6.42	0.74	1.73	0.49	1.24	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.16	4.12	0.82	0.14	0.00	0.55	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	5.15	8.36	2.25	0.64	0.32	1.29	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	11.56	11.87	1.22	1.22	1.22	1.22	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6.44	8.82	0.56	0.70	0.28	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.76	8.89	1.07	1.42	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	7.27	0.97	0.00	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.27	2.33	0.47	0.31	0.62	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.73	9.67	0.72	0.36	0.36	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.21	7.84	0.00	0.00	0.98	0.33	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.83	1.65	0.47	0.24	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	9.16	8.17	1.61	0.50	0.87	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.87	4.61	0.51	0.00	0.26	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.27	3.88	0.60	0.00	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	18.13	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	5.37	11.51	2.30	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	6.68	5.94	0.74	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	9.73	8.89	1.27	0.42	1.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.25	12.66	2.11	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	5.60	0.93	0.00	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	12.37	1.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	10.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.93	16.51	1.36	0.90	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.18	12.21	2.62	0.29	1.16	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.65	11.70	0.90	0.00	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.04	16.53	2.30	0.27	0.54	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.70	10.27	1.54	0.00	1.54	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.17	15.53	0.71	0.71	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.33	14.66	4.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.72	14.26	1.02	0.51	0.00	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	11.74	20.28	1.87	0.27	0.53	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	9.45	15.68	0.57	1.32	1.89	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	8.59	11.66	2.45	0.00	0.61	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	7.34	7.34	1.63	0.00	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.91	9.37	2.08	0.42	1.46	0.21	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	14.29	14.57	1.96	1.12	0.56	0.00	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	10.30	19.58	2.06	1.03	1.03	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.03	13.93	2.32	1.16	2.03	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	12.26	12.85	1.20	0.60	0.30	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.30	12.72	4.43	1.11	0.00	0.00	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	12.37	12.02	0.71	0.71	1.06	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	18.07	9.96	0.74	0.74	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	12.66	1.15	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.43	9.98	1.54	0.00	1.15	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.19	9.06	2.26	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	13.95	1.64	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	12.20	10.39	0.00	0.00	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.77	8.62	2.15	0.00	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	7.47	8.22	0.00	0.00	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	11.89	10.03	2.23	1.11	1.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.05	17.23	3.02	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.13	9.42	1.71	0.86	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.66	6.66	1.00	0.33	2.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	14.48	12.67	0.00	0.00	1.81	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.09	15.64	1.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	10.31	11.00	2.06	0.34	1.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	9.12	8.59	2.15	0.54	1.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	11.45	18.85	0.00	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	10.74	8.52	1.11	0.00	1.85	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	25.58	12.79	0.00	0.00	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	11.64	9.52	2.12	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	13.61	9.60	2.00	0.40	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.17	14.54	1.45	1.45	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.90	13.80	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	9.37	11.84	1.48	0.49	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	19.76	18.82	1.88	0.94	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	12.07	16.09	1.01	0.50	0.50	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.52	11.72	0.45	0.90	0.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	25.82	3.44	0.00	3.44	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.48	18.26	0.89	1.34	0.45	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	13.29	11.34	0.00	1.17	0.78	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	10.56	9.90	1.32	0.00	1.32	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	10.90	14.01	2.08	0.00	1.04	2.08	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	15.31	15.75	0.88	0.00	1.31	1.75	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	21.80	17.33	5.03	0.00	1.12	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.72	14.57	0.44	0.44	2.21	4.42	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.96	16.59	3.09	1.54	1.16	1.16	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.67	13.67	0.51	0.00	1.01	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	16.82	11.05	0.96	0.96	0.48	1.92	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	15.50	14.31	2.39	0.40	0.40	1.59	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	13.98	22.48	1.22	0.61	0.00	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	10.38	12.45	0.69	0.00	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.82	16.72	2.66	0.76	0.76	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	16.53	20.14	2.58	0.52	1.55	0.52	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.28	14.51	0.60	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	14.26	15.85	1.90	0.63	1.58	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	13.86	14.93	0.00	0.00	1.07	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	11.49	10.92	1.15	1.15	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	19.03	11.31	1.54	1.54	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	16.27	2.83	1.41	1.41	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.35	12.48	1.13	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	18.31	16.64	1.25	1.25	2.08	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	17.23	13.31	2.35	0.00	1.57	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	13.36	11.27	1.67	0.00	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	15.33	15.80	0.46	0.93	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.06	9.37	2.68	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.44	10.69	1.60	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.38	16.16	3.23	2.02	2.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	16.52	14.68	3.67	2.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.00	14.23	2.67	0.89	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.11	17.67	2.28	0.57	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.10	15.34	0.77	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.04	15.32	1.09	0.55	1.09	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	9.35	12.47	1.34	0.45	2.67	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	19.24	21.84	2.86	0.78	0.78	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	11.27	0.66	0.66	1.33	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	12.47	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	24.61	13.45	1.37	0.91	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	41.84	27.71	2.39	0.18	0.37	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	27.26	15.07	1.18	0.13	0.26	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	28.14	25.49	1.06	0.53	1.06	0.53	1.06
Mallassez-derived cells, donor2	11929-125I3	24.08	27.57	4.28	1.11	1.58	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	19.32	19.60	1.11	1.25	1.25	0.42	0.56
Mammary Epithelial Cell, donor1	11273-116H4	27.60	21.72	2.39	0.70	1.40	0.60	1.69
Mammary Epithelial Cell, donor2	11350-117G9	16.79	14.77	1.45	0.00	2.03	0.29	0.58
Mammary Epithelial Cell, donor3	11422-118F9	15.96	16.96	1.25	0.00	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	83.39	91.52	6.10	13.56	4.07	1.36	1.36
Mast cell, donor1	11563-120D6	29.09	26.28	1.95	0.76	0.54	0.22	0.32
Mast cell, donor2	11565-120D8	56.46	44.87	9.21	1.78	1.78	2.97	0.89
Mast cell, donor3	11566-120D9	40.07	28.14	5.18	2.03	1.80	0.45	0.23
Mast cell, donor4	11567-120E1	92.01	50.70	6.38	2.13	1.60	0.35	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	21.07	11.53	2.00	0.44	0.55	0.22	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	41.44	28.02	3.50	1.17	0.00	2.33	0.58
Mast cell, expanded, donor5	11939-126A4	39.01	23.63	2.75	0.34	0.46	0.00	0.11
Mast cell, expanded, donor8	11941-126A6	27.45	15.57	3.01	1.17	0.33	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	12.14	10.25	1.09	0.99	0.50	0.40	0.10
Melanocyte - dark, donor2	11582-120F7	11.07	12.46	1.38	0.00	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	18.33	14.71	1.67	0.14	0.36	0.00	0.14
Melanocyte - light, donor1	11274-116H5	16.22	14.81	1.88	0.24	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	10.24	10.92	2.73	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.88	8.67	4.34	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	20.83	20.20	1.98	0.31	0.31	0.00	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	23.13	16.41	1.34	0.27	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	21.43	22.50	2.14	0.27	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	16.38	15.63	1.12	0.25	0.00	0.37	0.00
Meningeal Cells, donor2	11573-120E7	9.68	11.44	0.88	0.00	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	28.36	29.83	2.04	0.08	0.57	0.57	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	26.80	21.10	2.00	0.29	0.29	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.66	28.68	4.83	0.40	0.40	0.60	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	2.63	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	7.85	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	35.16	17.94	0.72	0.00	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.71	12.49	1.69	1.27	0.85	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	23.62	27.65	2.51	0.00	1.01	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.69	4.61	0.00	0.00	0.22	0.00	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.15	9.50	0.00	0.00	0.73	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.03	11.46	1.23	0.20	0.20	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	18.14	14.27	2.77	0.14	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.60	2.97	0.74	0.00	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	18.03	19.21	1.84	0.00	0.66	0.00	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.97	2.37	1.19	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	7.01	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	3.84	0.64	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.74	35.44	1.42	0.00	1.42	1.06	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	13.76	15.95	2.81	0.31	1.25	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	19.59	8.71	1.45	0.73	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	29.70	36.86	2.65	0.27	0.80	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	33.53	39.54	8.01	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	25.29	36.57	2.53	0.51	0.65	0.51	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	121.53	70.22	2.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	49.25	34.72	1.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	53.89	27.38	3.24	1.18	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	96.80	51.86	17.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	39.05	21.70	4.34	0.00	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	34.64	19.08	1.45	0.21	0.21	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	83.38	74.11	6.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	29.03	26.03	1.75	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	47.94	28.39	4.65	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	38.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	28.86	22.35	0.81	1.02	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	43.16	25.34	2.38	0.79	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	145.38	85.51	8.55	0.00	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	21.24	16.81	0.88	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.77	18.62	0.38	0.76	0.38	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	77.64	36.85	9.21	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.68	20.37	1.91	0.42	0.00	1.91	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	44.20	31.31	2.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	36.36	32.79	0.89	0.00	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	78.80	40.24	3.35	3.35	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	237.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	31.36	28.85	2.76	0.25	0.00	0.25	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	30.18	17.59	0.48	0.24	0.24	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	76.85	65.24	8.85	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	27.17	33.62	2.99	0.00	0.00	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	31.34	24.40	1.89	0.63	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	39.14	34.45	1.63	0.41	0.00	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	28.32	22.10	1.50	0.00	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	32.01	25.34	2.00	0.22	0.22	0.67	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	123.82	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	30.44	36.58	4.82	0.66	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	46.64	27.88	1.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	82.85	67.94	11.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	47.29	47.02	2.45	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	35.58	28.82	1.76	0.59	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	89.41	62.15	6.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	27.39	30.76	2.40	0.00	0.00	0.48	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	49.63	25.61	2.40	0.00	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	98.73	76.79	2.74	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	39.55	28.53	3.00	1.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	75.42	57.08	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	35.03	27.15	3.50	0.44	0.44	0.00	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	82.77	60.70	4.41	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	74.93	49.31	3.84	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	32.23	31.49	2.98	0.25	0.00	0.25	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	60.54	34.10	4.87	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	110.49	75.14	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.22	19.15	2.05	0.34	0.00	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	56.45	42.89	2.63	1.75	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	51.49	58.24	1.78	0.36	0.36	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	25.25	13.47	3.09	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	38.65	31.59	2.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	58.27	41.37	1.75	0.00	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	29.86	16.29	1.81	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	31.30	21.70	2.50	1.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	57.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	25.86	15.70	1.85	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	52.93	35.29	1.14	1.14	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	28.88	19.35	1.11	0.28	0.14	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.95	14.51	1.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	34.75	24.45	1.29	0.43	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	49.54	25.41	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	23.75	17.08	1.33	0.53	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	38.01	18.86	0.90	1.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	22.60	18.79	0.85	0.00	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	20.07	14.65	0.32	0.00	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	45.11	31.40	0.88	0.66	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	44.37	23.89	1.52	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	19.04	17.90	1.42	0.00	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	26.30	20.16	0.49	0.74	0.49	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	33.89	23.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	29.11	24.40	1.76	0.59	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	37.77	22.20	1.15	0.00	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	40.80	22.67	0.82	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.99	17.57	2.38	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	15.07	0.00	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	8.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	25.63	10.84	0.99	0.33	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	23.14	7.36	2.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	31.23	12.65	0.79	0.20	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	39.12	24.21	1.86	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	23.28	15.02	2.63	0.38	0.00	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	22.11	8.52	0.53	0.27	0.27	0.00	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	32.35	17.98	1.36	0.11	0.11	0.23	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	19.15	11.79	0.74	0.00	0.00	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	22.72	15.02	1.10	0.00	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	20.22	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	33.67	13.90	1.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	11.59	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	18.18	13.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	26.14	15.60	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	19.07	20.43	2.72	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	7.63	4.45	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	6.48	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	7.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	108.49	0.00	5.71	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	45.67	55.46	9.79	6.52	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	19.01	9.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	62.75	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.99	21.97	1.94	0.22	1.51	0.00	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.54	18.29	2.09	0.52	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	10.01	0.00	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	6.68	9.18	0.00	0.42	0.00	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	23.01	20.73	1.14	0.38	0.19	0.76	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	23.94	33.51	1.60	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	3.40	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	38.59	33.08	1.84	1.84	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.53	5.86	0.00	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	14.41	9.53	0.23	0.00	0.46	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.97	8.38	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	28.59	23.34	1.89	0.21	0.00	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	11.13	11.13	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.47	8.93	0.50	0.00	0.00	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.24	8.66	0.00	0.00	0.81	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	11.79	6.12	0.00	0.00	0.00	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.59	6.86	0.00	0.16	0.33	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.75	7.11	0.73	0.18	0.18	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	12.20	3.71	0.00	0.00	0.00	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	11.41	3.60	0.00	0.60	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	15.75	15.10	2.30	0.66	0.33	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.08	5.85	0.00	0.33	0.16	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	13.23	14.99	0.71	0.18	0.88	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	4.92	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.33	10.11	0.92	0.92	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.71	9.00	0.64	0.00	0.00	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	12.76	14.14	1.03	0.34	1.72	0.34	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	50.57	37.93	7.59	0.00	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.49	18.71	0.89	0.89	0.89	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.70	8.89	1.69	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	15.67	12.82	0.47	0.24	0.24	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.01	7.30	0.00	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	45.14	36.11	0.00	9.03	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.00	5.66	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.53	7.66	0.90	0.45	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.86	11.51	0.00	0.00	0.79	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	8.36	1.86	0.00	0.93	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.24	11.35	0.38	0.00	0.38	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.15	4.89	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.20	7.84	0.87	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.19	10.40	2.71	0.00	1.81	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	7.06	0.00	0.00	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	12.63	4.65	0.00	0.00	0.00	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	16.87	6.45	0.50	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.63	5.36	0.00	0.00	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.10	13.31	0.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.70	13.26	1.77	0.22	1.11	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.91	12.88	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	71.53	0.00	0.00	0.00	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.75	4.27	0.00	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.55	7.87	0.94	0.31	0.31	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.47	5.15	0.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	3.16	0.00	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	23.81	26.07	3.40	0.00	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	40.46	5.06	0.00	15.17	0.00	0.00
Myoblast, donor1	11241-116D8	15.16	20.13	2.48	0.62	0.99	0.50	0.87
Myoblast, donor2	11322-117D8	21.86	20.14	2.88	0.38	0.38	0.00	0.58
Myoblast, donor3	11398-118D3	19.00	16.82	2.35	0.34	1.35	0.34	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.24	20.72	2.77	1.75	0.58	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	22.76	22.76	5.23	4.31	2.15	0.00	0.92
Natural Killer Cells, donor2	11311-117C6	16.59	22.01	8.44	3.32	3.32	0.00	0.90
Natural Killer Cells, donor3	11387-118C1	19.69	22.64	4.05	5.15	3.31	0.37	0.92
Neural stem cells, donor1	11275-116H6	49.72	51.90	4.36	0.36	0.73	0.36	0.00
Neural stem cells, donor2	11352-117H2	67.40	53.92	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	20.48	34.14	2.28	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	28.84	27.96	2.42	0.22	1.10	0.00	0.44
Neurons, donor3	11655-122E8	23.02	24.66	3.29	0.82	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	57.54	42.69	3.71	5.57	9.28	0.00	0.00
Neutrophils, donor2	11314-117C9	49.28	52.18	0.00	11.60	0.00	0.00	8.70
Neutrophils, donor3	11390-118C4	144.77	113.62	6.11	11.00	2.44	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	23.87	31.35	5.58	0.36	0.71	0.12	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	16.28	15.95	1.63	0.65	0.33	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	14.44	14.84	1.20	0.20	0.40	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	16.11	13.77	0.96	0.28	0.28	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	18.82	18.09	2.17	0.29	0.14	0.14	0.72
Olfactory epithelial cells, donor3	11935-125I9	21.45	15.55	1.93	0.23	0.11	0.00	0.57
Olfactory epithelial cells, donor4	11936-126A1	27.66	26.39	2.14	0.39	0.10	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	28.89	33.70	3.01	0.60	1.20	0.00	1.20
Osteoblast - differentiated, donor1	11276-116H7	24.67	28.50	6.38	0.00	0.21	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	5.72	6.86	3.43	0.00	1.14	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	10.55	4.34	1.24	0.00	0.62	0.62	0.62
Osteoblast, donor1	11277-116H8	16.22	15.44	2.15	0.00	0.20	0.39	0.20
Osteoblast, donor2	11354-117H4	18.26	23.88	1.40	0.00	1.40	0.00	1.40
Osteoblast, donor3	11426-118G4	33.95	43.72	5.33	0.36	0.53	1.60	0.53
Pancreatic stromal cells, donor1	11249-116E7	23.33	19.04	1.85	0.17	0.93	0.08	0.25
Pericytes, donor1	11491-119E6	2.67	1.67	0.56	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	2.94	2.26	0.45	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	6.10	5.90	1.02	0.00	0.20	0.20	0.41
Perineurial Cells, donor1	11499-119F5	10.28	6.56	0.45	0.11	0.90	0.00	0.57
Perineurial Cells, donor2	11579-120F4	14.35	13.16	1.66	0.28	0.18	0.09	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	29.96	25.18	3.19	2.87	2.87	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	22.28	20.08	2.94	2.20	1.47	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	24.33	22.65	1.81	4.27	1.68	0.26	0.00
Placental Epithelial Cells, donor1	11278-116H9	20.81	27.03	2.39	1.43	1.43	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	9.98	17.74	3.33	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.91	4.71	0.39	0.20	0.00	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.23	12.03	0.63	0.32	0.32	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	22.32	18.01	3.38	0.38	0.38	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	26.37	24.41	3.00	0.65	1.17	0.39	0.13
Preadipocyte - breast, donor2	11328-117E5	19.14	22.51	2.70	0.00	0.00	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	28.45	26.64	3.84	0.32	0.32	0.21	0.43
Preadipocyte - omental, donor2	11329-117E6	27.93	30.99	4.36	0.00	0.00	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	17.91	28.36	3.44	0.29	0.86	0.29	0.14
Preadipocyte - perirenal, donor1	11469-119C2	3.94	4.92	0.00	0.00	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	27.95	27.33	3.99	0.31	0.00	1.23	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	21.78	27.62	2.12	0.35	1.59	0.89	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	25.54	30.65	2.55	0.51	0.85	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	36.61	34.46	1.86	0.84	0.37	0.56	0.19
Preadipocyte - visceral, donor2	11357-117H7	28.07	25.31	3.22	0.46	0.46	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	14.21	18.29	1.36	0.42	0.21	0.73	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	16.29	19.61	1.66	0.75	1.66	0.00	0.45
Prostate Epithelial Cells, donor2	11331-117E8	18.55	26.68	2.30	0.81	0.41	0.27	0.27
Prostate Epithelial Cells, donor3	11404-118D9	17.88	22.54	1.41	0.80	1.53	0.31	0.24
Prostate Stromal Cells, donor1	11254-116F3	16.29	18.45	1.03	0.23	0.68	0.00	0.34
Prostate Stromal Cells, donor2	11332-117E9	25.46	24.92	1.61	0.18	0.36	0.18	0.90
Prostate Stromal Cells, donor3	11405-118E1	19.50	21.06	1.04	0.42	0.73	0.00	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.11	5.47	0.00	0.00	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	25.99	23.36	2.01	0.55	0.49	0.21	0.42
Renal Epithelial Cells, donor1	11517-119H5	6.59	5.58	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	3.56	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	37.48	26.68	3.28	0.85	0.95	0.53	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	4.09	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.72	15.90	1.21	0.81	0.40	1.35	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	24.64	25.98	4.44	0.44	1.11	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	3.99	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.26	7.04	0.88	0.22	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.02	1.88	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.22	2.50	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.05	8.32	0.54	0.27	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.75	3.37	0.00	0.00	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.68	7.91	1.16	0.00	0.58	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	31.11	25.15	2.07	0.00	1.30	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	1.99	0.57	0.28	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	2.06	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.61	30.11	4.01	0.25	0.25	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	39.69	23.39	2.54	0.94	0.27	0.00	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	42.88	26.80	0.89	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	55.59	41.83	2.20	1.10	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	64.39	59.17	12.18	1.16	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	32.90	31.34	2.08	0.52	0.52	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	29.69	26.71	2.68	0.40	0.40	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	51.08	38.59	2.45	0.56	0.56	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	41.06	27.91	1.74	0.62	1.98	0.12	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.04	24.24	1.52	0.47	1.05	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	54.32	39.75	1.62	0.23	0.46	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	30.39	27.24	2.33	0.14	0.27	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	35.10	35.55	2.27	0.45	1.36	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	47.49	37.81	2.33	0.36	0.36	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	26.97	22.24	1.58	0.14	0.00	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.36	22.21	1.40	0.64	0.32	0.11	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	37.62	29.43	1.99	0.44	0.44	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	25.24	25.24	1.34	0.00	0.57	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	35.22	26.55	1.58	0.28	0.47	0.28	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	70.84	43.41	2.82	0.00	0.38	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	32.38	34.37	2.92	0.53	0.13	0.66	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	39.81	47.02	1.65	0.88	0.58	0.19	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	45.07	34.75	1.53	0.57	1.34	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	25.52	21.36	0.96	0.75	0.53	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	27.19	29.43	1.12	0.56	2.52	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	47.51	35.55	2.22	0.51	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	30.81	31.54	1.46	0.18	0.36	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	27.71	19.87	1.72	0.98	0.74	0.37	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	39.22	44.33	2.28	0.94	0.67	0.13	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.59	24.77	0.94	0.24	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	27.58	19.05	0.79	0.60	0.79	0.20	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	47.70	38.35	1.87	0.23	0.47	0.23	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	20.11	23.64	2.07	0.41	0.41	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	33.62	26.32	2.65	0.44	0.44	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	50.55	33.42	1.88	0.21	0.63	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	28.53	25.57	1.21	0.54	0.00	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	55.18	52.79	1.53	1.02	0.68	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	62.08	56.68	2.51	1.16	0.77	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	18.91	18.74	0.52	0.52	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	38.68	32.51	2.47	0.41	0.96	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	53.03	46.46	3.28	0.49	1.15	0.16	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	21.64	22.84	0.34	0.68	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	15.68	14.50	1.18	0.30	1.04	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	54.38	46.91	1.07	1.07	0.27	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	24.47	19.91	1.11	0.41	0.14	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	15.00	13.33	2.86	0.24	0.95	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	60.06	31.64	3.43	0.81	0.20	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	20.06	12.71	1.13	0.19	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	15.02	13.28	1.05	0.00	1.05	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	31.73	25.39	4.84	0.60	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.34	20.44	0.73	0.49	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	26.05	19.50	2.04	0.29	1.46	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	35.90	25.55	1.22	0.61	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	20.50	17.48	0.90	0.30	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.52	21.04	1.81	0.00	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	49.42	35.94	1.80	0.00	0.90	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	21.73	22.32	3.19	0.47	0.47	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.34	29.46	5.98	0.85	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	46.88	45.67	2.40	1.20	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	4.51	5.27	0.38	0.38	0.38	0.00	0.00
Schwann Cells, donor2	11578-120F3	13.61	23.82	3.40	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	19.94	18.84	3.07	0.66	0.66	0.00	0.44
Sebocyte, donor1	11220-116B5	26.29	35.06	1.10	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	18.38	16.54	1.38	0.00	1.38	0.00	0.00
Sebocyte, donor3	11378-118B1	8.45	12.99	0.62	0.00	0.00	0.00	0.21
Sertoli Cells, donor1	11255-116F4	31.48	36.45	1.66	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	22.59	2.82	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	12.76	12.32	0.44	0.62	1.58	0.09	0.26
Skeletal Muscle Cells, donor2	11358-117H8	10.84	7.23	1.45	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	19.23	18.39	1.67	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	13.51	14.30	1.26	0.47	0.47	0.00	0.31
Skeletal Muscle Cells, donor5	11455-119A6	16.50	11.45	1.04	0.15	0.45	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	23.85	22.16	1.39	0.31	0.62	1.23	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	19.28	14.24	1.76	0.13	0.63	0.00	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.26	10.56	0.57	0.00	0.86	0.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	30.66	23.22	1.49	0.40	0.99	0.20	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	10.45	12.13	0.84	0.67	1.18	0.08	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	23.88	26.06	4.34	0.00	0.72	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.62	15.82	1.24	0.14	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	16.12	18.80	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	14.13	12.54	0.72	0.29	0.00	0.43	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	33.53	65.43	9.81	0.82	0.82	9.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.13	9.61	0.52	0.78	0.26	0.78	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	23.77	19.32	2.22	1.39	1.25	0.56	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	27.01	33.34	3.24	1.69	1.13	0.70	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	70.41	53.92	5.71	3.17	1.69	8.46	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	25.03	25.26	2.32	1.42	1.65	0.15	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.94	7.41	0.93	0.00	0.62	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	11.56	19.57	2.22	0.00	0.44	1.33	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	23.51	33.51	7.05	1.18	0.59	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	27.62	16.35	1.10	0.22	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.54	21.26	3.54	0.39	0.00	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	29.36	33.99	5.41	0.77	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	6.00	3.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	27.68	29.14	5.46	0.53	0.67	1.06	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	10.64	8.42	0.66	0.00	1.33	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	34.82	43.66	3.97	0.90	0.13	0.26	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	22.47	18.56	0.98	0.00	0.65	0.00	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.95	18.61	1.77	0.30	1.48	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	18.36	30.89	1.14	0.28	0.43	0.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.44	4.07	0.49	0.00	0.16	0.33	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	25.88	21.01	1.52	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	19.95	15.41	0.51	0.25	0.51	1.01	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	12.24	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	14.78	22.89	2.38	0.48	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.60	15.78	1.33	0.00	0.15	0.00	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	12.27	15.07	0.65	0.00	0.43	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.64	16.27	0.94	0.42	0.52	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.49	25.52	3.87	0.15	0.00	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	26.95	28.02	3.23	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	19.13	34.97	4.48	0.30	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.80	3.41	0.68	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	24.34	18.30	1.65	0.00	0.31	0.00	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	32.91	37.44	3.52	1.51	0.30	0.40	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	18.89	18.20	0.46	0.46	1.14	0.46	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.26	26.57	5.43	0.00	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	36.56	32.59	3.97	0.00	0.79	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	13.18	11.32	0.93	0.13	0.53	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	18.41	21.54	2.00	0.38	0.38	0.00	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	16.49	10.65	1.52	0.25	0.51	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	35.43	47.49	4.22	0.75	0.45	1.06	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	22.51	2.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	86.58	34.89	0.00	0.00	0.00	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.51	30.23	3.72	0.93	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.60	18.18	2.52	0.50	0.00	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.86	30.40	4.39	0.63	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.01	2.65	0.59	0.00	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	36.99	27.41	3.17	0.17	0.83	0.25	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.48	11.68	0.93	0.00	0.93	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	24.32	28.35	5.04	0.58	0.43	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	23.20	29.32	1.78	1.02	0.51	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	14.29	19.74	2.26	0.38	0.38	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	27.95	19.42	1.40	0.28	0.42	0.28	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.57	14.08	1.09	0.25	0.50	0.08	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	3.33	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	24.71	27.40	6.36	0.24	0.24	0.98	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	20.11	34.25	2.87	0.22	0.44	1.10	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	22.82	26.33	1.46	0.00	0.00	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.44	16.91	0.58	0.39	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.78	25.12	1.85	0.53	0.53	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	20.46	21.20	2.23	0.37	0.00	0.00	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	22.28	28.39	2.52	0.00	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	26.12	29.24	4.83	0.85	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.30	19.69	1.58	0.00	0.00	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	14.48	17.27	1.78	0.25	0.00	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	8.79	16.37	1.20	0.00	0.00	0.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	19.65	1.67	0.00	0.42	0.00	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	13.29	12.83	0.46	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	23.90	35.01	1.85	0.34	0.84	0.67	0.50
Synoviocyte, donor2	11368-117I9	5.53	5.53	0.84	0.17	1.17	0.17	0.50
Synoviocyte, donor3	11440-118H9	4.47	4.02	0.00	0.00	0.45	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	7.86	6.43	0.36	0.00	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	5.95	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.87	6.25	0.69	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	29.46	26.24	4.16	0.22	0.14	0.14	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	15.08	15.46	1.93	0.39	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	12.03	17.18	1.72	0.00	0.57	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	37.40	23.50	4.55	0.62	0.62	0.00	0.37
Urethra, donor2	10319-105A4	43.16	41.36	7.19	3.60	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	3.98	3.98	1.33	0.27	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	5.61	5.61	0.80	0.00	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	5.27	5.73	0.69	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	26.75	23.18	1.34	0.67	1.11	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	37.37	7.12	2.67	2.67	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	42.89	25.73	2.86	4.29	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	19.17	10.95	0.68	1.37	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	27.89	9.99	1.72	3.44	0.69	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.09	18.59	0.58	3.49	0.00	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	26.03	16.66	4.16	1.04	4.16	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	30.29	14.68	0.92	0.92	1.84	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	14.61	13.69	0.91	1.83	1.83	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	19.00	14.56	1.36	0.12	0.49	0.00	0.25
Wilms' tumor cell line:HFWT	10597-108E3	39.60	96.80	4.40	0.88	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	30.72	29.89	1.40	0.56	1.40	0.56	0.00
achilles tendon, donor2	10292-104G4	57.86	43.40	4.13	2.07	0.00	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	39.52	35.44	3.31	3.57	1.02	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	18.57	15.09	1.39	0.23	0.23	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	13.89	26.95	2.49	6.05	2.14	0.00	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	50.34	34.83	4.35	4.90	1.09	0.00	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	14.90	18.55	1.69	1.41	0.56	0.00	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	57.95	30.03	2.54	3.17	0.42	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	35.93	31.85	2.45	2.99	1.09	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	24.68	25.56	2.64	1.76	0.88	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	45.74	35.53	2.04	3.27	0.82	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	18.64	17.86	3.88	1.55	1.16	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	15.64	9.75	0.37	1.47	1.29	0.00	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	35.10	23.40	3.90	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	20.91	15.10	1.86	2.09	0.93	0.00	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	18.38	16.57	2.07	1.29	0.78	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	23.38	18.12	0.88	0.29	0.88	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	20.45	16.27	1.39	0.00	1.39	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	20.56	18.10	2.47	1.65	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	27.01	10.74	0.31	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	16.21	9.39	0.85	1.28	0.43	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	32.45	16.98	0.91	0.91	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	37.31	25.27	1.44	0.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	18.26	16.48	0.89	0.67	0.45	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	21.01	26.68	3.67	0.33	0.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	98.48	76.19	5.57	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	30.13	20.34	1.51	0.75	1.51	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	25.30	19.63	2.18	0.44	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	28.12	1.87	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	31.09	22.14	2.12	0.71	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	52.74	39.09	4.03	0.47	0.16	0.00	0.62
adipose, donor1	10184-103D4	58.64	43.98	4.69	1.17	2.35	0.00	3.52
adipose, donor2	10185-103D5	15.41	12.57	0.81	1.22	0.41	0.41	1.22
adipose, donor3	10186-103D6	38.12	23.14	1.36	1.09	1.63	0.00	0.54
adipose, donor4	10187-103D7	103.14	38.14	3.47	0.87	1.73	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	55.87	31.25	1.89	0.63	0.32	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	18.19	18.19	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	45.09	26.01	2.00	1.07	0.93	0.00	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	31.09	22.51	2.86	0.00	0.36	1.43	1.43
amniotic membrane cells, donor1	12235-129G3	31.76	18.55	3.01	1.62	0.93	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	29.08	17.24	2.70	0.34	0.34	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	29.75	18.27	3.54	1.18	0.29	0.29	0.59
amygdala - adult, donor10196	10167-103B5	35.57	26.09	2.37	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	31.83	26.16	6.08	0.61	1.42	0.00	0.41
amygdala, newborn, donor10223	10360-105E9	29.37	31.63	1.94	1.61	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	34.63	29.41	2.93	0.38	1.02	0.00	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	23.17	28.02	1.99	0.44	0.66	0.00	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	43.09	44.09	2.34	1.00	0.33	0.33	0.33
aorta, adult, pool1	10052-101G7	38.64	25.89	5.30	0.39	0.59	0.20	0.59
appendix, adult	10189-103D9	52.01	38.04	6.60	3.88	0.00	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	9.97	8.25	0.69	0.34	0.34	0.00	0.00
artery, adult	10190-103E1	58.42	92.39	9.51	1.36	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	7.82	10.87	1.16	0.29	0.43	0.29	0.58
b cell line:RPMI1788	10427-106D4	32.42	25.87	2.68	0.59	0.74	0.30	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	17.20	22.20	1.94	0.00	0.55	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	17.27	24.91	2.98	1.69	0.89	0.99	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	17.91	24.77	4.35	1.34	1.84	0.17	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	13.98	24.05	1.68	0.56	0.56	0.00	0.56
bladder, adult, pool1	10011-101C2	51.06	55.30	7.60	1.30	1.74	0.11	0.22
blood, adult, pool1	10053-101G8	24.36	8.86	4.43	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	16.27	28.26	3.43	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	12.82	9.45	1.35	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	26.65	13.33	3.08	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	35.08	25.95	3.67	0.67	1.56	0.00	0.45
brain, fetal, pool1	10085-102B4	34.73	24.04	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	44.27	57.48	3.96	0.66	0.66	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	16.60	13.48	1.00	0.00	0.87	0.00	0.00
breast, adult, donor1	10080-102A8	65.03	40.41	1.89	1.89	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	17.15	16.77	1.14	0.76	1.27	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.36	13.61	1.55	0.00	1.24	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	38.91	14.73	0.46	0.23	0.46	0.23	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	13.80	17.43	3.15	0.00	0.97	0.00	0.48
carcinoid cell line:NCI-H1770	10703-109H1	19.75	21.16	0.94	0.94	0.94	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	12.47	19.25	1.53	0.88	0.55	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	23.45	17.75	0.00	0.32	0.63	0.00	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	30.61	26.88	1.86	0.00	0.53	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	25.33	28.78	1.15	2.30	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	21.42	16.23	5.52	2.34	2.34	0.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	20.63	17.58	1.53	0.00	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	32.96	30.76	4.03	0.73	0.73	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	37.87	26.22	8.74	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	48.25	17.08	3.84	0.64	2.14	0.00	0.21
cerebellum, adult, pool1	10083-102B2	38.29	20.70	0.69	0.34	1.38	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	53.14	53.14	1.66	1.66	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	56.98	37.82	11.85	1.51	0.50	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	40.20	40.20	7.31	2.19	4.39	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	22.43	25.16	4.89	0.14	1.44	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	37.12	41.76	6.79	1.33	1.66	0.83	0.83
cervix, adult, pool1	10013-101C4	57.53	41.26	4.93	1.15	1.26	0.10	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	20.76	32.47	3.48	0.56	0.28	0.28	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	32.66	2.61	0.00	2.61	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	18.77	14.42	1.62	1.37	0.75	0.12	0.50
choriocarcinoma cell line:SCH	10785-110H2	20.95	18.73	2.34	1.11	0.99	0.00	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	22.06	17.08	2.61	2.13	0.24	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	23.08	17.67	4.27	1.99	1.14	1.42	0.28
chorionic membrane cells, donor2	12239-129G7	26.65	23.47	2.68	1.19	0.89	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	19.78	21.43	3.30	1.10	0.55	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	6.06	5.05	9.09	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	21.90	24.59	1.73	0.19	0.58	0.38	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	20.27	17.32	1.06	1.90	0.63	0.00	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	24.65	15.92	1.03	0.51	0.51	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	41.12	24.67	2.42	0.24	0.24	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	26.67	20.77	1.02	0.61	0.41	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	36.81	27.97	1.77	0.59	0.00	0.00	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	19.55	19.55	1.30	0.78	0.26	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	23.09	19.43	0.46	0.46	0.46	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	33.31	34.18	5.90	1.04	0.69	0.87	0.17
colon carcinoma cell line:CACO-2	10513-107D9	15.01	17.76	0.73	0.73	0.73	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	39.53	31.55	1.52	1.14	3.04	0.00	0.00
colon, adult, donor1	10082-102B1	46.41	20.23	5.95	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	44.53	38.19	8.93	0.71	0.82	0.00	0.24
colon, fetal, donor1	10070-101I7	36.46	24.72	3.09	1.24	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	146.67	68.75	18.33	9.17	13.75	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	69.69	73.09	8.50	1.27	0.42	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	32.15	28.98	2.26	1.66	0.75	0.15	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	36.10	34.55	2.82	0.71	0.28	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	32.17	33.50	6.08	0.55	1.33	0.00	0.22
cruciate ligament, donor2	10295-104G7	52.68	44.58	6.48	1.62	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	45.75	46.55	3.21	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	16.56	17.04	4.56	0.96	0.48	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	12.63	14.47	0.69	1.15	0.92	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	40.26	37.70	4.36	0.00	0.51	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	36.83	30.09	1.93	0.48	0.96	0.00	1.20
ductus deferens, adult	10196-103E7	36.38	27.91	5.98	1.00	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	34.57	4.32	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	20.60	19.13	1.47	0.74	1.47	0.00	0.74
dura mater, adult, donor1	10041-101F5	41.29	24.53	4.21	0.58	0.41	0.08	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	51.30	63.51	4.89	4.66	1.33	7.99	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	33.53	24.93	3.01	0.43	0.14	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	27.75	57.35	4.32	0.62	1.23	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	39.66	35.42	5.15	0.30	1.51	0.91	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	33.96	47.86	6.48	0.62	0.62	2.47	0.00
embryonic pancreas cell line:2C6	10603-108E9	21.02	51.23	5.25	1.31	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	57.65	70.06	3.69	1.34	1.34	1.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	47.30	34.07	3.44	0.72	1.09	0.00	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	14.15	14.15	2.09	0.16	0.32	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	59.69	81.48	4.45	1.33	0.78	1.00	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	27.50	37.73	2.75	1.10	0.66	1.43	0.22
epididymis, adult	10197-103E8	33.70	25.12	6.70	0.84	1.47	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	25.37	22.18	1.77	0.00	0.35	0.53	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	10.22	29.10	4.72	0.00	0.00	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	32.50	23.33	3.15	0.52	1.97	0.26	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	29.72	25.29	1.08	1.28	1.18	0.30	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.35	23.86	3.14	1.12	1.57	0.56	0.45
esophagus, adult, pool1	10015-101C6	47.78	34.08	3.61	1.27	0.53	0.00	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	26.80	19.66	2.63	0.63	0.38	0.38	0.38
eye - muscle inferior rectus, donor1	10272-104E2	31.39	70.02	14.49	4.83	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	42.08	37.88	10.52	2.10	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	61.02	86.32	10.42	1.49	5.95	0.00	0.00
eye - muscle superior, donor2	10297-104G9	37.83	35.54	8.03	2.29	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	11.66	1.46	1.46	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	25.17	20.08	2.29	0.51	0.76	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	16.16	20.52	1.41	1.15	1.41	1.54	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	36.56	28.49	2.14	0.71	0.24	1.90	0.00
frontal lobe, adult, pool1	10040-101F4	48.60	35.75	9.10	0.47	0.38	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	39.93	60.05	4.80	0.30	3.00	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	37.95	40.51	2.93	0.73	1.46	2.10	0.27
gall bladder, adult	10198-103E9	34.52	30.66	7.73	0.97	0.72	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	30.60	20.40	2.68	2.15	0.00	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	42.20	23.16	2.99	1.12	1.12	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	22.39	35.91	3.17	0.00	0.84	0.00	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	13.93	15.67	3.67	0.19	0.77	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	28.20	11.31	3.28	0.33	0.49	0.00	0.33
gastric cancer cell line:GSS	10560-108A2	13.73	3.66	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	27.19	35.87	4.80	1.37	0.91	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	29.60	22.37	2.41	0.23	1.26	1.72	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	26.45	22.39	2.94	1.26	2.10	3.36	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	27.44	20.20	5.49	0.50	1.25	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	25.33	35.68	3.80	0.74	0.53	0.00	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	30.48	35.95	3.93	0.56	0.70	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	18.10	17.66	0.66	0.22	0.44	0.00	0.33
glioma cell line:GI-1	10413-106B8	20.79	27.24	1.76	0.88	0.00	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	20.41	22.60	1.46	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	34.66	26.85	7.32	0.49	1.95	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	27.38	35.60	6.85	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	23.45	19.19	2.13	0.00	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	137.04	58.73	12.24	7.34	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	5.23	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	16.96	27.84	1.60	0.00	0.96	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	28.92	27.09	1.38	1.84	0.00	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	23.78	25.15	2.29	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	14.17	27.05	0.64	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	11.50	34.49	5.75	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	25.38	29.49	1.37	0.69	0.00	0.00	1.37
hIPS, biol_rep3	14382-156B8	14.35	22.07	4.41	1.10	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	25.29	15.52	1.15	0.00	0.86	0.57	0.29
heart - mitral valve, adult	10205-103F7	47.83	44.55	11.06	1.49	0.30	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	61.45	59.88	7.32	0.26	1.57	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	69.11	67.44	12.49	0.00	0.00	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	38.57	27.55	3.67	0.82	1.43	0.00	0.41
heart, adult, diseased, donor1	10051-101G6	46.42	33.64	2.55	3.83	1.70	0.00	0.00
heart, adult, pool1	10016-101C7	104.87	110.62	29.44	1.15	1.38	0.23	0.23
heart, fetal, pool1	10046-101G1	59.97	53.29	8.01	1.44	1.03	0.00	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	18.20	25.92	1.85	0.62	1.54	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	86.81	85.62	4.76	3.57	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.78	11.38	1.33	0.33	0.44	0.00	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	20.03	10.20	0.61	0.49	1.58	0.24	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	17.48	13.34	0.81	0.40	0.81	0.10	0.51
hepatoma cell line:Li-7	10484-107A7	23.02	35.70	3.67	1.78	1.78	0.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	19.40	18.79	1.21	0.70	0.70	0.00	0.20
hippocampus - adult, donor10196	10169-103B7	43.53	46.37	5.68	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	29.59	26.94	5.71	0.61	1.63	0.20	0.61
hippocampus, adult, donor10258	10374-105G5	13.44	20.42	1.99	0.00	1.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	22.91	23.62	4.23	1.06	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	36.62	37.84	6.10	1.22	0.00	0.00	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	23.56	16.89	0.98	0.79	0.20	0.39	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	39.61	43.67	2.54	1.27	0.00	0.25	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	23.68	19.74	0.00	0.56	0.00	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	28.66	15.23	1.55	1.29	0.00	0.00	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	37.58	26.19	1.14	0.76	0.76	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.71	38.83	2.04	2.04	1.75	0.58	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	32.96	23.70	1.72	1.72	1.51	0.00	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	32.53	36.29	2.09	0.42	0.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	30.31	27.23	3.55	0.95	2.13	0.00	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	29.41	26.36	3.21	1.93	0.96	0.00	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.91	20.20	4.04	0.67	2.69	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	28.95	20.34	1.56	1.25	0.47	0.16	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	24.07	27.02	3.44	0.98	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.06	30.55	4.36	2.62	2.62	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	41.43	21.57	2.48	0.57	0.95	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	39.25	26.16	1.31	0.00	0.44	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	31.48	28.49	2.50	0.00	2.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	25.43	15.07	1.51	0.75	0.94	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	25.92	11.37	0.45	0.45	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	20.36	15.04	1.88	0.31	1.25	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	17.80	15.51	1.63	0.16	0.65	0.16	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	17.42	15.10	2.32	0.00	0.87	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	20.03	13.75	1.79	0.00	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	27.34	24.39	1.66	1.11	0.37	0.18	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	23.39	23.96	1.71	1.71	0.57	0.29	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	38.38	35.11	2.45	0.82	0.41	0.41	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	24.65	15.14	1.06	0.35	1.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.29	15.84	0.95	0.00	0.32	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.63	23.91	1.51	0.00	0.00	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	13.96	18.62	1.03	0.00	1.55	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	20.59	17.93	0.00	0.00	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	22.32	23.34	2.57	0.77	0.51	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	12.78	16.87	2.05	0.77	1.02	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	24.23	23.47	1.51	2.27	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	15.12	22.85	2.35	0.00	0.00	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	26.81	21.01	1.69	1.45	0.48	0.00	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	34.32	23.62	2.23	0.45	0.45	0.45	4.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	29.76	33.66	2.44	1.46	0.00	0.49	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	29.03	20.78	1.53	0.00	0.92	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	165.92	123.62	9.76	0.00	9.76	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	41.04	27.47	0.99	1.32	1.99	0.00	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	18.06	15.87	1.64	0.55	1.09	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	15.56	15.92	2.17	0.36	1.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.93	15.66	2.14	0.36	0.71	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	17.90	1.19	1.19	4.77	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	20.86	17.61	2.57	1.63	1.76	0.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	16.16	15.09	2.16	1.08	0.27	0.00	1.08
immature langerhans cells, donor1	11904-125F5	41.16	32.21	4.12	2.42	1.21	1.21	0.48
immature langerhans cells, donor2	11905-125F6	45.94	45.94	2.38	3.96	1.58	1.58	0.00
insula, adult, pool1	10039-101F3	48.45	37.47	8.61	0.47	0.47	0.09	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	16.26	12.68	1.63	1.30	0.65	0.65	0.33
kidney, adult, pool1	10017-101C8	31.04	23.43	3.70	0.90	1.20	0.10	0.00
kidney, fetal, pool1	10045-101F9	26.38	21.22	3.18	0.42	0.64	0.14	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	29.82	29.54	2.41	0.28	0.71	0.99	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.37	12.44	0.55	0.14	0.14	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	38.35	59.64	4.95	2.20	2.39	0.73	0.18
left atrium, adult, donor1	10079-102A7	40.86	38.68	3.27	0.54	1.63	0.00	0.00
left ventricle, adult, donor1	10078-102A6	62.20	58.15	5.06	0.51	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	18.61	24.35	1.09	0.00	0.55	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	11.50	12.57	1.08	0.36	0.72	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	13.59	23.91	4.89	0.54	1.09	1.09	0.00
leiomyoma cell line:15425	10571-108B4	15.30	17.97	1.94	0.49	1.21	0.24	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	17.77	1.05	2.09	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	43.09	36.60	2.60	0.83	0.83	0.59	0.83
liposarcoma cell line:KMLS-1	10782-110G8	17.03	18.12	0.78	0.47	0.47	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	20.47	16.57	0.61	0.37	0.73	0.12	0.12
liver, adult, pool1	10018-101C9	22.53	30.63	3.57	0.49	0.32	0.00	0.00
liver, fetal, pool1	10086-102B5	23.52	16.93	1.88	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	29.60	24.50	3.21	0.44	1.17	0.00	0.29
locus coeruleus, adult, donor10252	10165-103B3	26.76	19.01	5.91	0.92	0.92	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	18.62	13.54	2.26	0.28	0.56	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	43.32	47.53	5.47	0.84	0.84	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	15.78	14.25	1.25	0.14	0.42	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	8.96	11.72	0.69	2.07	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	23.20	11.47	1.71	0.79	1.32	0.66	0.40
lung, adult, pool1	10019-101D1	44.06	34.61	2.36	0.59	0.83	0.12	0.12
lung, fetal, donor1	10068-101I5	61.93	56.23	9.13	1.43	0.86	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	27.49	25.66	2.75	1.83	2.75	0.00	0.46
lymph node, adult, donor1	10077-102A5	34.08	19.41	2.84	0.00	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	15.12	11.62	0.88	0.22	0.22	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	19.47	14.79	1.66	3.47	0.75	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	35.68	30.58	6.80	0.00	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	84.36	46.62	8.44	0.89	0.00	1.33	0.00
mature adipocyte, donor2	12232-129F9	68.90	42.96	6.23	0.62	1.25	0.62	0.21
mature adipocyte, donor3	12233-129G1	70.17	36.98	8.77	0.47	1.19	1.90	0.00
mature adipocyte, donor4	12234-129G2	69.49	41.06	9.48	0.00	0.53	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	38.36	15.96	1.91	1.19	1.19	0.00	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	34.97	20.30	3.38	2.26	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	34.21	23.36	4.60	0.55	2.57	0.00	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	22.56	23.19	1.91	0.64	0.64	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	54.59	47.77	10.66	1.28	1.28	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	26.33	18.73	1.52	1.18	2.19	0.00	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	30.35	18.89	5.52	0.21	1.27	0.00	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	21.19	5.78	0.00	1.93	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	114.83	100.48	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	32.66	32.30	2.87	0.72	0.00	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	22.07	22.07	1.95	0.00	1.95	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	20.90	19.97	3.56	0.93	0.93	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	35.43	29.39	6.45	0.57	0.73	0.00	0.16
medulla oblongata, newborn, donor10223	10361-105F1	25.34	25.69	2.78	0.35	0.35	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	27.23	22.14	2.66	0.22	1.33	0.00	0.44
medulloblastoma cell line:ONS-76	10759-110E3	30.20	29.47	2.81	1.22	1.10	0.61	0.12
melanoma cell line:COLO 679	10514-107E1	22.42	20.27	2.73	0.86	0.86	0.14	0.86
melanoma cell line:G-361	10465-106H6	27.15	35.56	1.36	1.63	0.81	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	20.98	19.36	1.81	0.90	0.72	0.72	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.03	22.91	0.88	3.52	2.64	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	26.70	23.59	2.85	1.56	0.78	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.51	10.13	1.38	0.15	0.46	0.31	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	8.54	11.63	1.64	0.18	0.18	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.01	12.01	2.07	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.54	7.73	0.42	0.00	0.00	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.24	8.86	0.58	0.19	0.39	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.94	10.41	2.08	0.00	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.44	10.30	0.69	0.17	0.34	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.01	8.51	1.04	0.35	0.23	0.12	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	10.08	8.49	0.93	0.13	0.66	0.66	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	16.07	15.80	1.62	0.27	0.95	0.95	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	19.77	28.31	2.13	0.43	1.00	0.28	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.17	17.79	0.99	0.00	0.33	0.00	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	20.48	21.59	1.66	0.28	0.69	1.52	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.64	33.51	2.09	0.35	0.00	0.35	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.07	14.70	1.84	0.20	0.61	0.61	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	15.10	24.08	2.52	0.36	0.36	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.83	8.28	1.34	0.00	0.21	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.78	26.22	2.74	0.68	0.23	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.98	23.91	5.03	0.00	2.52	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	12.85	14.94	1.34	0.30	0.30	0.60	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.99	14.36	1.23	0.26	0.35	0.88	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	18.78	14.36	1.47	0.74	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	20.60	30.05	4.29	0.29	0.00	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	33.26	35.79	3.37	0.42	0.84	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.59	9.59	0.91	0.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	14.58	14.32	1.53	0.26	0.00	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	13.09	18.85	1.05	0.79	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.47	11.40	1.54	0.31	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.77	10.36	0.71	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.82	10.83	1.35	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.54	11.00	1.57	0.00	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.41	8.34	0.46	0.00	0.00	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	10.67	13.84	0.29	0.29	0.29	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.60	9.82	0.45	0.00	0.22	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	10.34	8.89	0.72	0.00	0.48	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	15.40	15.40	0.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.07	7.38	1.68	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.05	8.60	0.41	0.00	0.41	0.00	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.02	11.17	0.00	0.00	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	5.16	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.42	11.04	1.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	5.82	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	12.26	5.86	0.53	0.53	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	11.45	2.45	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.39	11.66	0.39	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	8.39	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	6.95	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	8.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	9.75	0.00	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.33	6.97	1.27	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.62	7.59	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	4.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.70	3.67	0.81	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	11.92	0.00	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.90	5.90	0.00	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	6.23	5.61	1.25	0.00	0.31	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	0.00	6.68	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	15.37	1.18	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	5.14	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	14.46	18.59	1.38	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.89	11.38	0.99	0.00	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	7.85	0.00	0.00	1.12	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	10.81	10.18	0.64	1.27	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.90	12.90	0.81	0.40	0.40	0.00	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	13.08	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	16.47	0.00	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	20.63	19.42	1.82	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	9.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.00	11.53	2.47	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.30	7.54	0.60	0.00	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.03	12.01	1.62	0.00	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	17.32	1.02	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	32.50	26.31	6.19	0.77	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	38.51	26.70	1.65	0.00	0.47	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	20.62	25.25	2.32	0.46	0.70	0.23	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	29.92	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	18.50	23.32	2.67	0.82	1.13	0.72	4.93
mesothelioma cell line:Mero-25	10850-111F4	16.57	29.96	2.27	0.00	1.36	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	38.14	40.58	2.69	0.98	0.49	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	17.27	17.94	3.10	0.66	0.44	0.00	0.89
mesothelioma cell line:Mero-82	10853-111F7	24.70	28.65	2.89	0.53	2.63	0.53	0.26
mesothelioma cell line:Mero-83	10854-111F8	19.23	16.68	2.04	0.17	0.51	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	18.45	18.71	0.76	0.25	0.25	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	11.59	12.84	1.66	0.62	0.41	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	19.71	20.21	2.82	0.33	0.50	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	14.48	20.27	1.63	0.36	0.36	0.18	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	18.45	15.54	1.54	0.68	0.34	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	7.63	8.40	0.76	1.27	0.25	0.25	0.51
mesothelioma cell line:No36	10857-111G2	9.13	13.70	2.28	0.00	0.33	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	19.78	25.20	4.61	2.17	0.81	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	37.04	20.73	2.69	0.19	0.19	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	28.94	13.43	1.47	0.12	0.61	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	20.46	8.62	0.54	0.36	0.18	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	27.42	41.46	2.29	0.98	0.65	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	43.87	33.06	0.64	0.42	0.00	0.00	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	42.85	91.22	6.68	0.92	1.61	0.92	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	14.65	10.85	1.33	0.38	0.19	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	27.53	21.81	1.48	0.55	0.00	0.00	0.18
myeloma cell line:PCM6	10474-106I6	26.29	21.74	1.98	0.20	0.20	0.00	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	19.28	29.93	1.01	0.00	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	10.59	10.59	1.18	0.39	0.20	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	30.98	29.42	0.56	0.45	0.11	0.11	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	34.27	30.89	2.28	0.29	0.15	0.15	0.37
nasal epithelial cells, donor2	12227-129F4	48.58	38.09	3.86	1.10	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	18.63	27.38	4.14	1.38	1.61	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	17.59	16.65	2.25	0.19	0.56	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	20.03	21.09	1.90	1.69	1.90	0.00	0.84
neuroblastoma cell line:NH-12	10555-107I6	16.59	14.54	2.98	0.93	0.93	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	13.76	15.66	2.14	0.71	0.71	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	19.01	15.20	2.53	0.79	1.11	0.00	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	26.37	27.77	2.42	0.40	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	36.24	53.40	2.54	1.27	1.27	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	17.83	20.23	1.06	0.27	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	193.37	44.62	0.00	29.75	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	39.84	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	39.07	30.78	0.85	5.07	0.51	0.00	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	8.81	0.00	0.80	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	14.75	10.90	0.96	0.32	0.96	1.28	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	15.24	22.33	2.63	0.53	0.26	0.00	0.79
nucleus accumbens, adult, pool1	10037-101F1	40.78	35.34	8.16	0.94	1.12	0.00	0.19
occipital cortex - adult, donor10196	10172-103C1	30.91	22.66	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	33.28	25.49	5.10	0.27	2.68	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	53.14	42.22	6.19	0.00	0.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	38.31	34.90	8.13	0.79	0.52	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	66.08	33.90	1.72	0.43	1.29	0.00	0.43
occipital pole, adult, pool1	10036-101E9	26.49	18.76	4.81	0.16	0.55	0.00	0.08
olfactory region, adult	10195-103E6	31.52	27.13	7.83	0.76	1.34	0.00	0.19
optic nerve, donor1	10277-104E7	38.02	22.01	10.01	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	19.14	17.66	1.25	0.34	0.57	0.91	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	43.83	21.43	1.51	0.27	0.69	0.69	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.50	18.96	1.35	0.34	1.19	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	21.60	27.84	3.12	1.27	1.73	1.50	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	22.93	21.17	3.53	0.00	0.29	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	28.03	40.18	1.87	0.93	0.93	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	10.82	7.85	0.64	0.00	0.00	0.00	0.21
ovary, adult, pool1	10020-101D2	46.21	34.77	3.06	0.52	0.96	0.09	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.82	13.75	0.73	0.37	0.37	0.37	0.18
pancreas, adult, donor1	10049-101G4	18.81	18.81	2.82	0.00	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	10.90	12.30	1.40	0.00	0.28	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	25.04	48.21	2.04	1.87	0.51	0.17	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	20.70	26.00	2.81	2.48	1.82	2.15	0.33
paracentral gyrus, adult, pool1	10035-101E8	40.64	30.39	7.60	0.27	0.73	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	24.96	19.82	5.14	1.47	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	20.69	19.75	6.58	0.94	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	35.91	21.95	4.56	0.29	0.86	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	39.92	31.19	7.58	0.44	0.35	0.09	0.18
parietal lobe, fetal, donor1	10072-101I9	97.95	51.40	0.97	0.97	1.94	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	46.73	46.36	5.98	0.75	0.00	0.00	0.00
parotid gland, adult	10199-103F1	30.83	24.67	0.62	1.85	0.62	0.00	0.00
penis, adult	10200-103F2	31.15	25.24	8.06	0.54	0.54	0.00	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	31.42	17.29	2.42	0.93	1.12	0.00	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	20.25	18.07	2.33	0.58	1.31	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	32.25	27.09	1.94	0.65	1.29	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	37.31	30.80	7.11	0.00	2.96	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	34.49	33.86	1.88	0.00	0.63	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	33.39	14.17	1.01	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	53.68	22.93	4.17	0.00	2.08	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	25.54	18.73	3.40	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	53.11	33.54	4.84	0.54	0.22	0.00	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	16.82	24.63	2.52	1.06	0.40	0.00	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	32.37	26.46	3.27	0.31	0.62	0.00	0.00
pons, adult, pool1	10033-101E6	37.61	28.66	4.48	0.69	0.77	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	36.35	24.15	5.75	0.26	0.87	0.00	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	119.21	69.02	12.55	10.46	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	23.74	11.94	1.31	0.58	1.31	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	25.59	26.32	2.36	0.36	1.63	1.09	1.09
prostate, adult, pool1	10022-101D4	37.55	23.85	4.17	0.91	1.27	0.00	0.18
putamen, adult, donor10196	10176-103C5	31.87	23.13	5.67	2.12	3.07	0.24	0.24
putamen, adult, donor10252	10152-102I8	45.10	27.45	1.96	1.96	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	17.48	25.13	4.37	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	17.88	18.36	3.38	0.97	2.42	0.00	0.72
putamen, newborn, donor10223	10365-105F5	43.48	32.99	5.25	0.00	0.75	0.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	53.24	35.49	2.33	1.75	0.58	0.87	0.58
rectum, fetal, donor1	10067-101I4	59.81	52.86	1.39	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	29.04	15.90	1.48	0.85	1.06	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	21.12	8.70	1.66	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	30.62	21.57	2.88	0.10	0.50	0.10	0.00
retinoblastoma cell line:Y79	10475-106I7	45.47	30.66	1.56	2.08	1.30	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.42	8.61	0.49	0.12	0.00	0.00	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	70.86	80.70	7.59	1.69	3.94	0.28	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	16.67	21.22	4.55	0.00	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	16.19	14.41	1.46	0.00	0.49	0.49	0.49
salivary acinar cells, donor2	11772-123I8	13.49	9.36	1.51	0.69	0.55	0.00	0.41
salivary acinar cells, donor3	11773-123I9	29.79	26.48	1.99	0.00	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	20.59	13.73	4.00	1.14	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	37.10	33.39	2.53	0.34	0.51	1.77	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	36.79	30.80	3.17	0.35	0.59	2.12	0.47
seminal vesicle, adult	10201-103F3	39.15	29.63	7.41	1.06	1.06	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	40.33	61.22	8.75	2.43	2.19	5.34	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.60	11.07	3.02	0.25	0.25	0.75	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	30.11	27.10	1.00	2.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	18.54	13.97	1.34	0.54	1.34	0.27	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	35.37	41.23	6.08	1.44	1.22	0.11	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	13.29	13.55	2.32	0.90	0.65	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	114.20	149.67	24.12	3.55	7.09	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	109.26	135.65	33.58	4.08	5.04	0.00	0.36
skeletal muscle, fetal, donor1	10066-101I3	34.17	27.14	1.01	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	20.36	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	30.30	22.72	3.16	2.52	0.00	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	14.01	9.67	1.00	0.33	0.33	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	20.49	34.36	4.10	0.63	1.58	0.00	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	40.28	24.29	2.51	0.58	0.77	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	31.65	29.67	3.46	2.14	2.31	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	60.32	33.62	1.93	0.97	1.77	0.00	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	33.56	29.64	4.14	3.27	1.96	0.00	0.22
small intestine, adult, pool1	10024-101D6	34.88	25.20	3.34	0.96	0.72	0.12	0.36
small intestine, fetal, donor1	10064-101I1	33.17	18.67	1.72	0.74	0.49	0.00	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	16.93	15.39	3.08	2.05	1.03	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	47.81	41.61	12.41	0.78	1.03	0.00	0.52
somatostatinoma cell line:QGP-1	10781-110G7	21.17	24.12	2.95	0.80	2.14	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	24.09	16.29	2.52	0.46	0.92	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	29.57	27.99	5.52	0.39	3.55	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	15.91	28.36	4.84	0.00	2.08	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	43.91	34.15	6.10	0.61	0.61	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	26.63	37.66	4.13	0.92	0.92	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.40	24.64	2.99	1.34	1.05	0.45	0.15
spleen, adult, pool1	10025-101D7	39.65	25.00	1.76	1.65	0.33	0.11	0.44
spleen, fetal, pool1	10044-101F8	35.44	26.30	3.18	1.51	0.40	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	14.39	8.59	1.04	0.62	0.41	0.00	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	41.96	35.13	2.28	0.57	0.38	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	34.25	25.16	3.15	0.70	3.49	0.00	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	35.18	76.23	5.08	1.56	0.78	3.52	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	86.22	120.44	9.45	3.04	2.36	0.90	0.90
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	24.99	25.84	0.42	0.42	0.42	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	48.65	41.46	2.96	0.00	0.42	0.00	0.85
stomach, fetal, donor1	10062-101H8	55.53	37.38	2.14	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	41.59	28.48	6.27	1.71	1.71	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	23.47	19.32	4.78	1.25	2.91	0.21	1.04
substantia nigra, adult, donor10258	10371-105G2	18.10	19.14	2.07	0.00	0.52	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	30.38	36.74	3.53	0.71	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	46.08	29.12	3.44	0.69	0.46	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	31.28	26.11	4.07	0.76	0.42	0.00	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	85.47	51.28	3.56	0.00	2.14	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	59.78	35.16	4.83	0.88	0.44	0.00	0.88
tenocyte, donor1	11763-123H8	11.87	7.68	1.05	0.00	1.05	0.00	1.05
tenocyte, donor2	11765-123I1	7.25	9.16	0.38	0.00	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	13.34	10.75	2.22	0.00	0.74	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	44.87	43.34	4.25	0.85	1.53	0.00	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	28.83	26.51	2.47	1.70	1.08	0.15	0.62
teratocarcinoma cell line:PA-1	10807-111A6	19.22	31.77	1.08	0.31	0.77	0.15	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	32.63	34.28	3.17	1.14	0.51	0.63	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	52.94	46.14	3.78	0.38	1.13	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	32.28	28.47	2.94	1.20	0.65	0.11	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	34.85	28.99	1.95	0.33	0.65	0.00	1.63
testis, adult, pool1	10026-101D8	69.04	53.47	6.23	0.86	0.86	0.00	0.43
testis, adult, pool2	10096-102C6	52.33	29.77	5.86	0.90	2.26	0.00	0.45
thalamus - adult, donor10196	10168-103B6	29.81	18.77	4.42	0.00	0.00	0.00	2.21
thalamus, adult, donor10252	10154-103A1	25.94	20.79	5.63	1.09	0.78	0.00	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	30.79	10.78	1.54	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	15.97	12.35	1.81	0.49	0.33	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	25.31	36.25	3.45	0.58	0.58	0.00	0.00
throat, adult	10209-103G2	51.68	52.18	19.22	1.75	1.25	0.00	1.00
throat, fetal, donor1	10061-101H7	25.90	16.15	0.61	1.52	1.22	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	27.03	15.50	0.99	0.00	0.40	0.20	0.00
thymus, adult, pool1	10027-101D9	30.82	35.49	6.86	13.22	2.29	0.00	0.20
thymus, fetal, pool1	10043-101F7	35.54	40.63	8.42	12.68	3.01	0.00	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	26.73	17.42	1.86	0.53	0.40	0.66	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	22.91	21.23	1.12	1.40	0.70	0.28	0.14
thyroid, adult, pool1	10028-101E1	39.19	31.45	3.64	1.21	1.96	0.09	0.37
thyroid, fetal, donor1	10060-101H6	47.46	43.50	3.95	1.58	1.58	0.53	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	49.27	12.32	0.00	6.16	0.00	0.00
tongue, adult	10203-103F5	49.31	55.59	7.21	0.93	1.63	0.00	0.70
tongue, fetal, donor1	10059-101H5	42.17	40.20	0.79	1.18	1.58	0.00	0.00
tonsil, adult, pool1	10047-101G2	40.97	27.05	3.81	1.30	0.50	0.00	0.10
trachea, adult, pool1	10029-101E2	34.27	24.05	1.96	1.39	0.90	0.25	0.16
trachea, fetal, donor1	10058-101H4	36.55	36.16	1.92	1.15	0.38	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	21.61	22.67	2.83	0.00	1.42	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	38.20	45.69	2.03	2.13	1.42	0.81	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	29.30	21.00	0.78	0.63	0.94	0.47	0.31
tridermal teratoma cell line:HGRT	10694-109G1	19.03	30.44	3.81	0.00	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.37	15.58	1.69	0.34	0.51	0.25	0.34
umbilical cord, fetal, donor1	10057-101H3	27.12	22.95	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	28.84	31.91	4.95	0.34	0.34	0.00	0.17
uterus, fetal, donor1	10055-101H1	40.95	30.20	2.05	2.56	0.51	0.00	0.51
vagina, adult	10204-103F6	58.80	58.16	6.46	0.00	3.23	0.00	0.00
vein, adult	10191-103E2	25.65	25.21	3.95	2.41	0.66	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.75	9.08	0.80	0.53	0.27	0.00	0.27